Placebo-controlled biofeedback blood pressure effect in hypertensive humans

American Heart Association
Publication Type:
Journal Article
Hypertension, 1997, 29 (6), pp. 1225 - 1231
Issue Date:
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2010004406OK.pdf842.05 kB
Adobe PDF
The role of biofeedback in blood pressure control remains ill-defined because of nonspecific (placebo) effects, small study numbers, and the technical limitations of continuous pressure feedback. Clarification of its potential is awaited by those seeking a nonpharmacological approach to blood pressure control. This study examines the capability for systolic pressure lowering of 5 mm Hg or more using continuous pressure feedback in a statistical sample of untreated, wellcharacterized, mildly hypertensive individuals. Subjects were randomized in a double-blind study to active or placebo biofeedback. Placebo consisted of a modified contingency approach, using a partial disguise based on a digital high pass filter with 15 elements. Blood pressure-lowering capability was assessed during two laboratory sessions.
Please use this identifier to cite or link to this item: